Protara Therapeutics, Inc. Operating Expenses
Protara Therapeutics, Inc. (TARA) reported Operating Expenses of $23.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-11
- Protara Therapeutics, Inc. operating expenses for the quarter ending 2026-06-30 was $23.32M, a 40.62% increase year-over-year.
- Protara Therapeutics, Inc. operating expenses for the quarter ending 2026-03-31 was $19.63M, a 38.98% increase year-over-year.
- Protara Therapeutics, Inc. operating expenses for the quarter ending 2025-12-31 was $19.08M, a 33.31% increase year-over-year.
- Protara Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $14.76M, a 19.71% increase year-over-year.
- Protara Therapeutics, Inc. operating expenses for fiscal 2025 was $64.55M, a 31.32% increase from fiscal 2024.
- Protara Therapeutics, Inc. operating expenses for fiscal 2024 was $49.15M, a 12.70% increase from fiscal 2023.
- Protara Therapeutics, Inc. operating expenses for fiscal 2023 was $43.61M, a 34.97% decline from fiscal 2022.
- Protara Therapeutics, Inc. operating expenses for fiscal 2022 was $67.06M, a 41.22% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $23.32M 10-Q · filed 2026-08-11 | $42.95M 10-Q · filed 2026-08-11 | $62.03M derived: sum of 3 quarters · filed 2026-08-11 | $76.79M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $19.63M 10-Q · filed 2026-05-13 | $38.71M derived: sum of 2 quarters · filed 2026-05-13 | $53.47M derived: sum of 3 quarters · filed 2026-05-13 | $70.05M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $19.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $33.84M derived: sum of 2 quarters · filed 2026-03-10 | $50.42M derived: sum of 3 quarters · filed 2026-08-11 | $64.55M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $14.76M 10-Q · filed 2025-11-10 | $31.35M derived: sum of 2 quarters · filed 2026-08-11 | $45.47M 10-Q · filed 2025-11-10 | $59.78M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $16.59M 10-Q · filed 2026-08-11 | $30.71M 10-Q · filed 2026-08-11 | $45.02M derived: sum of 3 quarters · filed 2026-08-11 | $57.35M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $14.12M 10-Q · filed 2026-05-13 | $28.44M derived: sum of 2 quarters · filed 2026-05-13 | $40.77M derived: sum of 3 quarters · filed 2026-05-13 | $51.43M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $14.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $26.64M derived: sum of 2 quarters · filed 2026-03-10 | $37.30M derived: sum of 3 quarters · filed 2026-03-10 | $49.15M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $12.33M 10-Q · filed 2025-11-10 | $22.99M derived: sum of 2 quarters · filed 2025-11-10 | $34.84M 10-Q · filed 2025-11-10 | $45.88M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $10.66M 10-Q · filed 2025-08-11 | $22.51M 10-Q · filed 2025-08-11 | $33.55M derived: sum of 3 quarters · filed 2025-08-11 | $44.25M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $11.85M 10-Q · filed 2025-05-08 | $22.89M derived: sum of 2 quarters · filed 2025-05-08 | $33.59M derived: sum of 3 quarters · filed 2025-05-08 | $45.73M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $21.74M derived: sum of 2 quarters · filed 2025-03-05 | $33.88M derived: sum of 3 quarters · filed 2025-03-05 | $43.61M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | $10.70M 10-Q · filed 2024-11-12 | $22.84M derived: sum of 2 quarters · filed 2024-11-12 | $32.57M 10-Q · filed 2024-11-12 | $72.08M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $12.14M 10-Q · filed 2024-08-06 | $21.87M 10-Q · filed 2024-08-06 | $61.38M derived: sum of 3 quarters · filed 2024-08-06 | $69.36M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $9.73M 10-Q · filed 2024-05-02 | $49.24M derived: sum of 2 quarters · filed 2024-05-02 | $57.22M derived: sum of 3 quarters · filed 2024-05-02 | $65.92M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $39.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $47.48M derived: sum of 2 quarters · filed 2024-03-13 | $56.19M derived: sum of 3 quarters · filed 2024-03-13 | $67.06M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $7.97M 10-Q · filed 2023-11-03 | $16.68M derived: sum of 2 quarters · filed 2023-11-03 | $27.55M 10-Q · filed 2023-11-03 | $37.84M derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | $8.71M 10-Q · filed 2023-08-03 | $19.58M 10-Q · filed 2023-08-03 | $29.87M derived: sum of 3 quarters · filed 2023-08-03 | $40.70M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $10.87M 10-Q · filed 2023-05-04 | $21.16M derived: sum of 2 quarters · filed 2023-05-04 | $31.99M derived: sum of 3 quarters · filed 2023-05-04 | $44.78M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $10.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $21.12M derived: sum of 2 quarters · filed 2023-03-08 | $33.91M derived: sum of 3 quarters · filed 2023-03-08 | $47.49M 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | $10.83M 10-Q · filed 2022-11-03 | $23.62M derived: sum of 2 quarters · filed 2022-11-03 | $37.20M 10-Q · filed 2022-11-03 | $46.16M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $12.79M 10-Q · filed 2022-08-09 | $26.37M 10-Q · filed 2022-08-09 | $35.33M derived: sum of 3 quarters · filed 2022-08-09 | $43.39M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $13.58M 10-Q · filed 2022-05-05 | $22.54M derived: sum of 2 quarters · filed 2022-05-05 | $30.60M derived: sum of 3 quarters · filed 2022-05-05 | $37.87M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $8.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $17.02M derived: sum of 2 quarters · filed 2022-03-09 | $24.29M derived: sum of 3 quarters · filed 2022-03-09 | $34.44M 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | $8.06M 10-Q · filed 2021-11-04 | $8.06M 10-Q · filed 2020-11-12 | $15.33M derived: sum of 2 quarters · filed 2021-11-04 | $25.49M 10-Q · filed 2021-11-04 | $25.49M 10-Q · filed 2020-11-12 | $28.01M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $7.27M 10-Q · filed 2021-08-05 | $7.27M 10-Q · filed 2020-07-31 | $17.43M 10-Q · filed 2021-08-05 | $17.43M 10-Q · filed 2020-07-31 | $19.95M derived: sum of 3 quarters · filed 2021-08-05 | $22.30M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $10.16M 10-Q · filed 2021-05-06 | $10.16M 10-Q · filed 2020-05-13 | $12.68M derived: sum of 2 quarters · filed 2021-05-06 | $15.03M derived: sum of 3 quarters · filed 2021-05-06 | $16.46M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $4.87M derived: sum of 2 quarters · filed 2021-03-11 | $6.30M derived: sum of 3 quarters · filed 2021-03-11 | $7.83M 10-K · filed 2021-03-11 | $15.25M 10-K · filed 2020-03-20 | |||
| 2019-09-30 | $2.35M 10-Q · filed 2020-11-12 | $1.59M 10-Q · filed 2019-10-31 | $3.78M derived: sum of 2 quarters · filed 2020-11-12 | $5.31M 10-Q · filed 2020-11-12 | $13.61M 10-Q · filed 2019-10-31 | $10.70M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $1.43M 10-Q · filed 2020-07-31 | $5.39M 10-Q · filed 2019-08-07 | $2.96M 10-Q · filed 2020-07-31 | $12.02M 10-Q · filed 2019-08-07 | $8.34M derived: sum of 3 quarters · filed 2020-07-31 | $12.96M derived: sum of 4 quarters · filed 2020-07-31 | ||
| 2019-03-31 | $1.53M 10-Q · filed 2020-05-13 | $6.64M 10-Q · filed 2019-05-08 | $6.91M derived: sum of 2 quarters · filed 2020-05-13 | $11.54M derived: sum of 3 quarters · filed 2020-05-13 | $16.54M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $5.38M 10-K · filed 2019-03-13 | $10.01M derived: sum of 2 quarters · filed 2019-10-31 | $15.01M derived: sum of 3 quarters · filed 2019-10-31 | $21.37M 10-K · filed 2020-03-20 | ||||
| 2018-09-30 | $4.62M 10-Q · filed 2019-10-31 | $9.62M derived: sum of 2 quarters · filed 2019-10-31 | $15.99M 10-Q · filed 2019-10-31 | $21.58M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | $5.00M 10-Q · filed 2019-08-07 | $11.37M 10-Q · filed 2019-08-07 | $16.95M derived: sum of 3 quarters · filed 2019-08-07 | $29.26M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $6.37M 10-Q · filed 2019-05-08 | $11.96M derived: sum of 2 quarters · filed 2019-05-08 | $24.26M derived: sum of 3 quarters · filed 2019-05-08 | $30.25M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $5.59M 10-K · filed 2019-03-13 | $17.90M derived: sum of 2 quarters · filed 2019-03-13 | $23.88M derived: sum of 3 quarters · filed 2019-03-13 | $30.36M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $12.31M 10-K · filed 2019-03-13 | $18.29M derived: sum of 2 quarters · filed 2019-03-13 | $24.77M 10-Q · filed 2018-11-07 | $31.64M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | $5.99M 10-K · filed 2019-03-13 | $12.47M 10-Q · filed 2018-08-07 | $19.33M derived: sum of 3 quarters · filed 2019-03-13 | $26.50M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | $6.48M 10-K · filed 2019-03-13 | $13.35M derived: sum of 2 quarters · filed 2019-03-13 | $20.51M derived: sum of 3 quarters · filed 2019-03-13 | $28.37M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | $6.87M 10-K · filed 2018-03-14 | $14.03M derived: sum of 2 quarters · filed 2018-03-14 | $21.89M derived: sum of 3 quarters · filed 2018-03-14 | $28.70M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $7.17M 10-K · filed 2018-03-14 | $15.02M derived: sum of 2 quarters · filed 2018-03-14 | $21.84M 10-Q · filed 2017-11-07 | $28.03M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-06-30 | $7.85M 10-K · filed 2018-03-14 | $14.67M 10-Q · filed 2017-08-07 | $20.86M derived: sum of 3 quarters · filed 2018-03-14 | $25.94M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2016-03-31 | $6.82M 10-K · filed 2018-03-14 | $13.01M derived: sum of 2 quarters · filed 2018-03-14 | $18.09M derived: sum of 3 quarters · filed 2018-03-14 | $23.07M derived: sum of 4 quarters · filed 2018-03-14 | ||||
| 2015-12-31 | $6.19M 10-K · filed 2017-03-16 | $11.27M derived: sum of 2 quarters · filed 2017-03-16 | $16.25M derived: sum of 3 quarters · filed 2017-03-16 | $20.87M 10-K · filed 2018-03-14 | ||||
| 2015-09-30 | $5.08M 10-K · filed 2017-03-16 | $10.06M derived: sum of 2 quarters · filed 2017-03-16 | $14.68M 10-Q · filed 2016-11-07 | $17.96M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $4.98M 10-K · filed 2017-03-16 | $9.60M 10-Q · filed 2016-08-08 | $12.87M derived: sum of 3 quarters · filed 2017-03-16 | $15.69M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $4.62M 10-K · filed 2017-03-16 | $7.89M derived: sum of 2 quarters · filed 2017-03-16 | $10.71M derived: sum of 3 quarters · filed 2017-03-16 | $13.21M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | $3.27M 10-K · filed 2016-03-14 | $6.09M derived: sum of 2 quarters · filed 2016-03-14 | $8.60M derived: sum of 3 quarters · filed 2016-03-14 | $10.53M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | $2.81M 10-K · filed 2016-03-14 | $5.32M derived: sum of 2 quarters · filed 2016-03-14 | $7.25M 10-Q · filed 2015-11-12 | $9.04M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $2.51M 10-K · filed 2016-03-14 | $4.44M 10-Q · filed 2015-08-13 | $6.23M derived: sum of 3 quarters · filed 2016-03-14 | $8.14M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $1.93M 10-K · filed 2016-03-14 | $3.72M derived: sum of 2 quarters · filed 2016-03-14 | $5.63M derived: sum of 3 quarters · filed 2016-03-14 | $7.18M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2013-12-31 | $1.79M 10-K · filed 2015-03-20 | $3.70M derived: sum of 2 quarters · filed 2015-03-20 | $5.25M derived: sum of 3 quarters · filed 2015-03-20 | $7.12M 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | $1.91M 10-K · filed 2015-03-20 | $3.46M derived: sum of 2 quarters · filed 2015-03-20 | $5.33M 10-Q · filed 2014-11-25 | |||||
| 2013-06-30 | $1.55M 10-K · filed 2015-03-20 | $3.42M derived: sum of 2 quarters · filed 2015-03-20 | ||||||
| 2013-03-31 | $1.87M 10-K · filed 2015-03-20 | |||||||
| 2012-12-31 | $8.00M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |